Targeted Therapy in NSCLC Part VI: Immune Therapy

Save

In the sixth and final part of this series on targeted therapy in non small cell lung cancer (NSCLC), the current status of immune therapy will be reviewed. Although immune therapy for cancer has been a research topic for more than 30 years, it has only recently undergone clinical development. Of note this year are […]